SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001117480-24-000007
Filing Date
2024-03-21
Accepted
2024-03-21 08:31:53
Documents
15
Period of Report
2024-03-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cmrx-20240320.htm   iXBRL 8-K 33812
2 chimerixlogoa02.jpg GRAPHIC 13737
6 EX-99.1 exhibit991bodchanges.htm EX-99.1 7344
  Complete submission text file 0001117480-24-000007.txt   185014

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cmrx-20240320.xsd EX-101.SCH 1904
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cmrx-20240320_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cmrx-20240320_pre.xml EX-101.PRE 13048
18 EXTRACTED XBRL INSTANCE DOCUMENT cmrx-20240320_htm.xml XML 2811
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Filer) CIK: 0001117480 (see all company filings)

IRS No.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35867 | Film No.: 24769580
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)